Office of Grant Writing & Publications.

The Dana Foundation

Office of Grant Writing & Publications

202 Jesse Hall
University of Missouri
Columbia, MO 65211

573 882-9500 phone
573 884-8371 fax

Limited Submission Announcement

The Dana Foundation requests proposals for its Neuroimmunology Program focusing on brain infections and cancers. The Foundation invites studies of 1) immune-based therapies for primary brain tumors and for metastases to the brain of other cancers; 2) immune responses to infections in the brain, including but not limited to viral encephalitis, meningitis, cerebral malaria, and prion diseases; and 3) how immune functions are carried out and modified in the brain. The following are examples of the areas of focus:

• Exploring ways to stimulate immune cell recognition and attack of primary brain tumors and metastases
• Measuring responses to therapeutic vaccines or other immunotherapies for treating brain tumors
• Determining ways to prevent and defend against viral infections in the brain
• Examining ways to treat infections in the brain, including cerebral malaria
• Characterizing the roles of immune cells in normal brain and how these functions are modified under abnormal brain conditions.

This program focuses on clinical studies in humans or human tissues. Animal studies that are directly relevant to human disease, but not ready for application to studies of humans or human tissues, will also be considered. Emphasis is placed on support for tenure-track researchers who are early in their careers: at the assistant professor level, or early in their associate professor careers. Established researchers pioneering efforts in brain infections and cancers, however, are also eligible to apply. Postdoctoral fellows are not eligible.

Because MU is limited to one application for this program, letters of intent must be submitted to the Office of Research,, no later than 4:00 pm Friday, March 6, 2009. Letters of intent should be limited to a three-page summary of the project, including 1) research hypotheses; 2) aims of the research project; 3) the significance and potential clinical application(s) of the research; and 4) qualifications of the primary investigator(s


$200,000 total over a period of up to three years.

MU Deadline for letter of intent::

4:00 p.m., Friday, March 6, 2009

Sponsor Deadline:

Required preliminary proposal due April 1, 2009. Full proposals will be by invitation only.

URL for more information:

This notice is being sent to deans, directors, and chairs in health and life science disciplines. Please forward it to other faculty members who may be interested.

All limited submission announcements can be tracked by deadline via the Calendar at or by announcement date via the Limited Submissions listing at